# Inhibikase Therapeutics, Inc.: Form S-1, filed Jun 18, 2024

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: S-1
- Filed: 2024-06-18
- Accepted by EDGAR: Jun 18, 2024, 17:27 ET
- Period: not reported
- Accession: 0001193125-24-163529
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000119312524163529/d804510ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000119312524163529/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000119312524163529/d804510ds1.htm

Filed Jun 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-163529. Last ingested by Listed: Nov 11, 2026, 02:12 ET. No prices; not investment advice.
